Having trouble accessing articles? Reset your cache.

Merck ends I-vation deal

Merck (NYSE:MRK) ended a 2007 deal with SurModics (NASDAQ:SRDX) to develop SurModics' I-vation sustained delivery system for

Read the full 178 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE